Connective Capital Management’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-185,712
Closed -$176K – 91
2026
Q2
$176K Buy
+185,712
New +$172K 0.12% 51
2026
Q1
– Sell
-150,340
Closed -$131K – 76
2025
Q4
$131K Buy
+150,340
New +$162K 0.08% 48

Other funds holding ONCY

Connective Capital Management's ONCY Position: Q3 2026 in Review

Connective Capital Management sold out of Oncolytics Biotech (ONCY) in Q3 2026, closing a stake of 185,712 shares — an estimated $176K sold.

Connective Capital Management first reported a position in ONCY in Q4 2025 and held it in 2 quarters. The position peaked at $176K in Q2 2026. 77 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • Connective Capital Management reported no remaining Oncolytics Biotech position as of Q3 2026 after selling out during the quarter.
  • Connective Capital Management sold 185,712 Oncolytics Biotech shares in Q3 2026, an estimated $176K.
  • Connective Capital Management first reported a position in Oncolytics Biotech in Q4 2025 and held it in 2 quarters.
  • Connective Capital Management's Oncolytics Biotech position peaked at $176K in Q2 2026.
  • 77 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on Connective Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.